Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI)

Historical Holders from Q3 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
TOI on Nasdaq
Shares outstanding
87,441,936
Price per share
$3.55
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
33,859,364
Total reported value
$118,161,510
% of total 13F portfolios
0%
Share change
+2,377,770
Value change
+$9,179,418
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
106
Price from insider filings
$3.67
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SARIN RAVI YANG 4.7% $5,548,191 4,109,771 Ravi Sarin 26 Mar 2025
As of 30 Sep 2025, Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) has 106 institutional shareholders filing 13F forms. They hold 33,859,364 shares. of 87,441,936 outstanding shares (39%) .

Top 25 institutional shareholders own 35% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 5.2% 4,545,245 +6.2% 0% $15,862,905
BlackRock, Inc. 3.9% 3,434,875 +3.9% 0% $11,987,713
DEERFIELD MANAGEMENT COMPANY, L.P. 3.8% 3,360,052 0% 0.18% $11,726,581
CenterBook Partners LP 3.1% 2,704,650 +278% 0.47% $9,439,229
Balyasny Asset Management L.P. 2.9% 2,518,337 0% 0.02% $8,788,996
Kanen Wealth Management LLC 2.1% 1,842,101 2.1% $6,420,611
WEXFORD CAPITAL LP 1.8% 1,571,069 +40% 1.7% $5,483,030
GEODE CAPITAL MANAGEMENT, LLC 1.6% 1,401,906 +9.6% 0% $4,893,399
STATE STREET CORP 1.3% 1,130,025 +75% 0% $3,943,787
UBS Group AG 1.2% 1,055,862 +151% 0% $3,684,959
MILLENNIUM MANAGEMENT LLC 1.1% 951,001 +135% 0% $3,318,993
TIFF ADVISORY SERVICES, LLC 0.98% 856,628 -76% 0.62% $2,989,632
RENAISSANCE TECHNOLOGIES LLC 0.86% 750,500 +64% 0% $2,619,245
GOLDMAN SACHS GROUP INC 0.78% 681,643 +341% 0% $2,378,934
Manatuck Hill Partners, LLC 0.72% 629,800 +152% 0.75% $2,198,002
NORTHERN TRUST CORP 0.53% 464,692 +13% 0% $1,621,775
Massar Capital Management, LP 0.46% 400,000 0% 0.5% $1,396,000
FourWorld Capital Management LLC 0.41% 358,000 -8.6% 3% $1,249,420
TWO SIGMA INVESTMENTS, LP 0.32% 278,967 +0.29% 0% $973,595
LPL Financial LLC 0.31% 266,985 0% $931,778
BOOTHBAY FUND MANAGEMENT, LLC 0.28% 247,884 0.02% $865,115
EHP Funds Inc. 0.28% 244,041 1.1% $851,703
FreeGulliver LLC 0.24% 210,000 -39% 0.33% $732,900
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 0.23% 204,250 -92% 0.57% $712,833
NKCFO LLC 0.22% 190,000 0.2% $663,000

Institutional Holders of Oncology Institute, Inc. - Common Stock, par value $0.0001 per share (TOI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 16,297 $57,570 -$42,552 354.74% 2
2025 Q3 33,859,364 $118,161,510 +$9,179,418 349% 106
2025 Q2 31,474,503 $64,523,702 +$31,211,543 205% 78
2025 Q1 16,901,932 $19,267,414 +$2,727,937 114% 42
2024 Q4 14,712,600 $4,608,917 -$2,191,792 30.9% 30
2024 Q3 20,589,694 $6,982,762 +$385,706 32.69% 34
2024 Q2 18,701,866 $8,832,828 +$175,317 46% 39
2024 Q1 17,219,312 $27,205,023 -$2,896,495 158% 43
2023 Q4 18,371,129 $37,476,149 +$6,560,156 204% 43
2023 Q3 15,107,160 $21,169,015 +$1,157,360 140% 36
2023 Q2 13,916,036 $7,656,522 -$4,489,113 55.02% 36
2023 Q1 21,905,923 $14,849,783 -$1,309,677 67.79% 37
2022 Q4 23,473,725 $38,729,748 -$1,207,208 165% 37
2022 Q3 23,312,268 $107,936,806 +$6,608,838 463% 36
2022 Q2 21,873,424 $110,679,000 +$3,302,877 506.01% 32
2022 Q1 17,791,143 $126,852,000 -$752,301 713.05% 27
2021 Q4 21,118,138 $199,883,000 +$185,679,055 975% 21
2021 Q3 252,439 $2,504,000 +$2,503,993 991.92% 1